IPO Comments to USPTO Regarding Proposed Real-Party-in-Interest Disclosure Requirements for Ex Parte Reexamination Requests
IPO Comments to USPTO Regarding Proposed Real-Party-in-Interest Disclosure Requirements for [...]
IPO’s 119th Congress Legislative Tracker
IPO's 119th Congress Legislative Tracker
IPO Comments to China National Copyright Administration on Draft Amendments to the Implementing Regulations of China’s Copyright Law
IPO Comments to China National Copyright Administration on Draft Amendments to [...]
IPO Letter to U.S. Senate Opposing S. 2658, the Medication Affordability and Patent Integrity Act
IPO Letter to U.S. Senate Opposing S. 2658, the Medication [...]
IPO Comments to CNIPA Regarding Administrative Adjudication and Mediation of Patent Disputes
IPO Comments to CNIPA Regarding Administrative Adjudication and Mediation of [...]
Letter to U.S. House Committee on the Judiciary Regarding Hearing on the ETHIC Act and Skinny Labels, Big Savings Act
Letter to U.S. House Committee on the Judiciary Regarding Hearing [...]
IPO Comments on USPTO Supplemental Guidance Related to Design Patent Applications for Computer-Generated Interfaces and Icons
IPO Comments on USPTO Supplemental Guidance Related to Design Patent [...]
IPO’s Request to the National Data Administration for an Extension of Time re: Comments on the “Guidelines for Data Property Rights Registration (Trial)”
IPO’s Request to the National Data Administration for an Extension [...]
IPO Comments to CNIPA on Draft Amendments to the Measures for the Administration of Patent Priority Examination
IPO Comments to CNIPA on Draft Amendments to the Measures [...]
IPO Comments on Draft Agreement on Cross-Border Aspects of Client-Patent-Attorney Privilege
IPO Comments on Draft Agreement on Cross-Border Aspects of Client-Patent-Attorney [...]
Posts tagged here will show on the testimony and comments page.